Pharma Bio World - November 2015Add to Favorites

Pharma Bio World - November 2015Add to Favorites

Go Unlimited with Magzter GOLD

Read {{magName}} along with {{magCount}}+ other magazines & newspapers with just one subscription  View catalog

1 Month $9.99

1 Year$99.99

$8/month

(OR)

Subscribe only to Pharma Bio World

Buy this issue $0.99

Subscription plans are currently unavailable for this magazine. If you are a Magzter GOLD user, you can read all the back issues with your subscription. If you are not a Magzter GOLD user, you can purchase the back issues and read them.

Gift Pharma Bio World

In this issue

Both biosimilars and biobetters are derivative variants of the original biologic molecule. While biosimilars, as the term suggests, aim to establish similarity to a known biological, biobetters seek superiority in one or various aspects of their clinical profile. The November issue, themed on Biosimilars and Biobetters, covers complexities involved in developing biosimilars and biobetters, building cost-effective models for the manufacturing, logistics issues etc. Besides technical articles based on latest biotech research will also be featured.

Pharma Bio World Magazine Description:

PublisherJasubhai Media Pvt. Ltd.

CategoryBusiness

LanguageEnglish

FrequencyMonthly

Pharma Bio World is a comprehensive business magazine that caters to the strategic information needs of senior professionals in the pharmaceutical and biotechnology industries, covering the best manufacturing and management practices, technological developments, new markets and cutting edge products and services. Through a well-defined combination of news analyses, snapshots of major happenings, and thoroughly researched features on best practices, quality, biotechnology, environment, markets, human resources, and so on, the magazine aims to provide well-rounded information on issues of strategic interest to practicing managers in the industry.

  • cancel anytimeCancel Anytime [ No Commitments ]
  • digital onlyDigital Only
MAGZTER IN THE PRESS:View all